Skip to content

Clinical trials

Terminated Lung Diseases, Interstitial trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Terminated Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20112
20161
20171
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
EMD Serono Research & Development Institute, Inc.1
Furiex Pharmaceuticals, Inc1
Gilead Sciences1
Laval University1
Maisonneuve-Rosemont Hospital1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Thunder Bay Regional Health Research Institute1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial10
Pulmonary Disease, Chronic Obstructive4
Hypertension, Pulmonary3
Idiopathic Pulmonary Fibrosis3
Pulmonary Fibrosis3
Cystic Fibrosis2
Fibrosis2
Lung Diseases2
Respiratory Tract Diseases2
Respiratory Tract Infections2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.